Z. Rahman

发表

Lack of activity of stealth liposomal doxorubicin in the treatment of patients with anthracycline-resistant breast cancer

G. Hortobagyi, V. Valero, D. Booser, 2002, Cancer Chemotherapy and Pharmacology.

High-dose chemotherapy with autologous stem cell support in patients with breast cancer.

G. Hortobagyi, A. Buzdar, R. Champlin, 1998, Cancer treatment reviews.

Results and long term follow‐up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin‐containing chemotherapy

Terry L. Smith, G. Hortobagyi, R. Theriault, 1999, Cancer.

Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.

G. Hortobagyi, N. Ueno, B. Andersson, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer.

G. Hortobagyi, A. Buzdar, R. Champlin, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer.

G. Hortobagyi, V. Valero, D. Booser, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy.

P. Thall, G. Hortobagyi, R. Giles, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Prospective assessment of cardiac toxicity during a randomized phase II trial of doxorubicin and paclitaxel in metastatic breast cancer.

G. Hortobagyi, R. Theriault, A. Buzdar, 1997, Seminars in oncology.

Phase I–II Vinorelbine (Navelbine®) by Continuous Infusion in Patients with Metastatic Breast Cancer: Cumulative Toxicities Limit Dose Escalation

R. Bast, G. Hortobagyi, V. Valero, 2001, Cancer investigation.

Phase II study of vinorelbine administered by 96‐hour infusion in patients with advanced breast carcinoma

R. Bast, G. Hortobagyi, V. Valero, 1999, Cancer.

Phase I Study of Vinorelbine and Docetaxel with Granulocyte Colony-Stimulating Factor Support in the Treatment of Metastatic Breast Cancer

G. Hortobagyi, V. Valero, N. Ibrahim, 2002, Cancer investigation.

Prospective randomized trial of paclitaxel alone versus 5-fluorouracil/doxorubicin/cyclophosphamide as induction therapy in patients with operable breast cancer.

G. Hortobagyi, S. Singletary, F. Ames, 1997, Seminars in oncology.

Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer.

S. Heimfeld, M. Andreeff, R. Giles, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I/II study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer.

G. Hortobagyi, V. Valero, R. Champlin, 1997, Seminars in oncology.

Combination chemotherapy with paclitaxel and doxorubicin for metastatic breast cancer.

G. Hortobagyi, R. Theriault, A. Buzdar, 1997, Seminars in oncology.

A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer.

G. Hortobagyi, V. Valero, N. Ibrahim, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.

Terry L. Smith, D. Berry, G. Hortobagyi, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study.

D. Mutch, D. Miller, K. Leslie, 2014, Gynecologic oncology.

Phase II Trial of Weekly Docetaxel/Irinotecan Combination in Advanced Pancreatic Cancer

Laurie Thomas, Gina Chung, R. Salem, 2007, Cancer journal.

A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancer.

G. Hortobagyi, V. Valero, N. Ibrahim, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection.

A. Buzdar, M. Munsell, N. Ueno, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical course of breast cancer patients with metastases confined to the lungs treated with chemotherapy. The University of Texas M.D. Anderson Cancer Center experience and review of the literature.

G. Hortobagyi, V. Valero, A. Buzdar, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer.

R. Bast, G. Hortobagyi, V. Valero, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evofosfamide, a new horizon in the treatment of pancreatic cancer

M. Young, Z. Rahman, M. Pourmorteza, 2016, Anti-cancer drugs.

Chemotherapy‐induced neutropenia and fever in patients with metastatic breast carcinoma receiving salvage chemotherapy

G. Fraschini, H. Yap, Z. Rahman, 1997, Cancer.

Phase I S tudy o f S tealth L iposomal D oxorubicin i n Combination W ith G emcitabine i n t he T reatment o f Patients W ith M etastatic B reast C ancer

R. Bast, G. Hortobagyi, V. Valero, 2001 .